In the BioHarmony Drug Report Database

"Preview" Icon

Ospemifene

Osphena, Senshio (ospemifene) is a small molecule pharmaceutical. Ospemifene was first approved as Osphena on 2013-02-26. It is used to treat atrophy, dyspareunia, and menopause in the USA. It has been approved in Europe to treat postmenopause. Osphena’s patents are valid until 2028-07-09 (FDA).

 

Trade Name

 

Senshio
 

Common Name

 

ospemifene
 

ChEMBL ID

 

CHEMBL2105395
 

Indication

 

atrophy, dyspareunia, menopause, postmenopause
 

Drug Class

 

Antiestrogens of the clomifene and tamoxifen groups

Image (chem structure or protein)

Ospemifene structure rendering